Vodafone Group (LON:VOD) Price Target Raised to GBX 230

Share on StockTwits

Vodafone Group (LON:VOD) had its price objective boosted by Bank of America from GBX 219 ($2.88) to GBX 230 ($3.03) in a research note released on Thursday, Stock Target Advisor reports. Bank of America currently has a buy rating on the cell phone carrier’s stock.

A number of other analysts have also weighed in on VOD. UBS Group restated a buy rating on shares of Vodafone Group in a research report on Friday, November 15th. Deutsche Bank restated a buy rating and issued a GBX 240 ($3.16) target price on shares of Vodafone Group in a research report on Wednesday, November 13th. HSBC set a GBX 190 ($2.50) target price on shares of Vodafone Group and gave the company a buy rating in a research report on Thursday, September 19th. JPMorgan Chase & Co. cut their target price on shares of Vodafone Group from GBX 225 ($2.96) to GBX 220 ($2.89) and set an overweight rating on the stock in a research report on Tuesday, November 12th. Finally, Citigroup restated a buy rating and issued a GBX 185 ($2.43) target price on shares of Vodafone Group in a research report on Thursday, November 7th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and fourteen have assigned a buy rating to the stock. The company presently has a consensus rating of Buy and a consensus target price of GBX 193.38 ($2.54).

Vodafone Group stock traded up GBX 1.90 ($0.02) during mid-day trading on Thursday, reaching GBX 146.24 ($1.92). The company had a trading volume of 72,772,859 shares, compared to its average volume of 61,020,000. Vodafone Group has a fifty-two week low of GBX 122.22 ($1.61) and a fifty-two week high of GBX 169.46 ($2.23). The company has a current ratio of 0.99, a quick ratio of 0.93 and a debt-to-equity ratio of 124.73. The company has a market cap of $39.29 billion and a P/E ratio of -5.19. The business has a fifty day simple moving average of GBX 155.28 and a 200 day simple moving average of GBX 146.62.

The firm also recently declared a dividend, which will be paid on Friday, February 7th. Stockholders of record on Thursday, November 28th will be paid a dividend of €0.05 ($0.05) per share. The ex-dividend date is Thursday, November 28th. This represents a dividend yield of 2.41%. This is an increase from Vodafone Group’s previous dividend of $0.04. Vodafone Group’s dividend payout ratio (DPR) is presently -0.28%.

In other news, insider Vivek Badrinath sold 162,062 shares of the firm’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of GBX 153 ($2.01), for a total transaction of £247,954.86 ($326,170.56).

About Vodafone Group

Vodafone Group Plc engages in telecommunication services in Europe, Africa, the Middle East, and the Asia Pacific. The company's consumer products include mobile services, such as call, text, and data; broadband; television offerings and voice; mobile money services through M-pesa; Giga TV, an advanced digital service; and converged communication solutions, such as GigaKombi, Vodafone One Net Enterprise, Vodafone One, and Vodafone Meet Anywhere.

Further Reading: What is a death cross?

Analyst Recommendations for Vodafone Group (LON:VOD)

Receive News & Ratings for Vodafone Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vodafone Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Spire Healthcare Group  Earns Add Rating from Peel Hunt
Spire Healthcare Group Earns Add Rating from Peel Hunt
RPS Group  Upgraded to Add at Peel Hunt
RPS Group Upgraded to Add at Peel Hunt
Gattaca  Price Target Cut to GBX 85 by Analysts at Liberum Capital
Gattaca Price Target Cut to GBX 85 by Analysts at Liberum Capital
Cubic  Scheduled to Post Earnings on Wednesday
Cubic Scheduled to Post Earnings on Wednesday
Oxford BioMedica  Earns Buy Rating from Peel Hunt
Oxford BioMedica Earns Buy Rating from Peel Hunt
Shield Therapeutics’  “Corporate” Rating Reiterated at FinnCap
Shield Therapeutics’ “Corporate” Rating Reiterated at FinnCap


© 2006-2020 Ticker Report